Biomedista has conducted an extensive analysis of the companies with the largest portfolio shares in public reimbursements in Turkiye, shedding light on the significant contributors to the healthcare market. The findings highlight the top 10 companies that dominate this sector, demonstrating their vital roles in advancing healthcare solutions.
The analysis reveals that Medtronic is the leading company with the largest portfolio share in public reimbursements, accounting for an impressive 19.3 billion TL, which represents 14.35% of the market. This substantial share underscores Medtronic’s pivotal position and influence within the Turkish healthcare industry.
Johnson & Johnson Medikal Sanayi holds a prominent position, securing a portfolio share of 16.8 billion TL, equivalent to 12.53% of the market. This significant share highlights the company’s robust presence and commitment to the Turkish healthcare sector.
TIPMED and TST Rakor Lead Turkish Reimbursement Market with Significant Shares
TIPMED Tıbbi Medikal Ürünler Sanayi also emerges as a key player, capturing a substantial 15.1 billion TL, or 11.24% of the market. This figure underscores TIPMED’s strategic importance and competitive edge in providing medical products and services. TST Rakor ve Tıbbi Aletler Sanayi follows with a notable portfolio share of 14.0 billion TL, representing 10.44% of the market. The company’s contributions reflect its critical role in the medical device sector and its impact on public health.
TİPSAN Tıbbi Aletler Sanayi ve Ticaret holds a significant share as well, with 12.7 billion TL, accounting for 9.49% of the market. This share highlights TİPSAN’s commitment to delivering quality medical equipment and services. Zimmer Biomet Tıbbi Cihazlar Sanayi has secured a portfolio share of 12.3 billion TL, representing 9.12% of the market. The company’s contributions to the medical device industry are vital in enhancing healthcare delivery and patient outcomes.
EFMED, Stryker, and Carl Zeiss Among Top Companies in Turkey’s Reimbursement Market
EFMED Tıbbi Aletler Ltd. Şti. holds a significant portfolio share of 11.8 billion TL, equating to 8.75% of the market. This share underscores EFMED’s role in providing essential medical tools and technologies. Stryker Tıbbi Cihazları Sanayi ve Ticaret has captured a share of 11.4 billion TL, representing 8.46% of the market. The company’s presence highlights its importance in the Turkish medical devices sector.
HİPOKRAT Tıbbi Malzemeler İmalat contributes 11.2 billion TL to the market, accounting for 8.34% of the total share. This figure underscores the company’s impact and dedication to improving healthcare solutions. Lastly, Carl Zeiss Meditec Medikal Çözümleri rounds out the top 10 with a portfolio share of 9.8 billion TL, representing 7.3% of the market. Carl Zeiss’s contributions are vital in providing innovative medical solutions and advancing healthcare technologies.
The analysis of these companies not only highlights the leaders in the market but also underscores the competitive and dynamic landscape of the healthcare industry in Turkiye. These companies’ dedication to innovation and excellence in medical technology plays a crucial role in enhancing public health and ensuring the availability of quality healthcare services.
Resource: <a href="https://www.linkedin.com/posts/biomedista_healthcare-reimbursement-dataanalysis-activity-7217565913342963712-8rAc/?utm_source=share&utm_medium=member_desktop”>Biomedista, July, 2024
This article has been prepared with the assistance of AI and reviewed by an editor. For more details, please refer to our Terms and Conditions. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author.
